CHIZF Dividend: China Traditional Chinese Medicine Holdings Co Ltd Yield Insights

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	15,587	16,509	18,121	14,304	19,052	14,806
Revenue Growth (YoY)	-9%	-9%	27%	-25%	28.99%	3%
Cost of Revenue	8,157	8,653	8,847	7,105	7,223	5,680
Gross Profit	7,429	7,856	9,274	7,198	11,829	9,126
Selling, General & Admin	6,402	6,582	7,455	5,559	8,570	6,294
Research & Development	584	596	685	611	694	550
Operating Expenses	6,805	7,104	7,924	6,023	9,118	6,611
Other Non Operating Income (Expenses)	-24	-24	-29	-19	-18	--
Pretax Income	-219	163	1,224	840	2,520	2,230
Income Tax Expense	115	142	-171	119	396	369
Net Income	-264	54	1,285	764	1,932	1,663
Net Income Growth	-129%	-96%	68%	-60%	16%	5%
Shares Outstanding (Diluted)	5,035.8	5,035.8	5,035.8	5,035.8	5,035.8	5,035.8
Shares Change (YoY)	0%	0%	0%	0%	0%	0%
EPS (Diluted)	-0.05	0.01	0.25	0.15	0.38	0.33
EPS Growth	-129%	-96%	68%	-60%	16%	5%
Free Cash Flow	--	2,071	680	565	-81	-1,023
Free Cash Flow Per Share	--	0.41	0.13	0.11	-0.01	-0.2
Gross Margin	47.66%	47.58%	51.17%	50.32%	62.08%	61.63%
Operating Margin	4%	4.54%	7.44%	8.2%	14.22%	16.97%
Profit Margin	-1.69%	0.32%	7.09%	5.34%	10.14%	11.23%
Free Cash Flow Margin	--	12.54%	3.75%	3.94%	-0.42%	-6.9%
EBITDA	--	1,881	2,483	2,273	3,559	3,198
EBITDA Margin	--	11.39%	13.7%	15.89%	18.68%	21.59%
D&A For EBITDA	--	1,130	1,133	1,099	849	684
EBIT	624	751	1,350	1,174	2,710	2,514
EBIT Margin	4%	4.54%	7.44%	8.2%	14.22%	16.97%
Effective Tax Rate	-52.51%	87.11%	-13.97%	14.16%	15.71%	16.54%

China Traditional Chinese Medicine Holdings Co Ltd (CHIZF) Price